Previous 10 |
Procaps to Introduce Senior Leadership Team, Review Reported Second Quarter 2021 Financial Results and Full Year 2021 Guidance with Analysts and Investors Management to Provide Expected Milestone Timeline for Upcoming Business Combination with Union Acquisition Corp. II ...
Second Quarter 2021 Net Revenues Expected to Increase Over 25% Year-Over-Year, Resulting in First Half of 2021 Increasing Over 30% Year-Over-Year Company to Report on Second Quarter 2021 Results and Provide Full Year 2021 Guidance on August 12, 2021 Analyst Day and Inv...
Company Reaffirms Full Year 2021 Net Revenue Guidance of $397 Million and Adjusted EBITDA Guidance of $105 Million Business Combination Remains on Track to Close in the Third Quarter of 2021 Procaps Group, a leading integrated international healthcare and pharmaceuti...
First Quarter 2021 Net Revenues Increased 36% to $80.5 Million Year-Over-Year with Adjusted EBITDA Up 103% Year-Over-Year Company Reaffirms Revenue and Adjusted EBITDA Growth Trajectory for Second Quarter of 2021 Procaps Group, a leading integrated international heal...
Company to Provide Second Quarter 2021 Outlook Procaps Group, a leading integrated international healthcare and pharmaceutical company, that entered into a definitive business combination agreement with Union Acquisition Corp. II (NASDAQ: LATN, LATNU, LATNW) (“LATN...
Senior Executive from Abbott Laboratories Latin American EPD Division to Accelerate Procaps Group’s Rollout of Global Growth Initiatives & Strengthen Its Management Team Procaps Group Reports Unaudited First Quarter 2021 Net Revenues of $78.7 Million, a 33% Increase...
Declining SPAC IPOs could indicate the SPAC bubble may have run its course. Brookfield Asset Management agrees to acquire Brookfield Property Partners after increasing its bid by 10%. Aggregate deal value in a highly competitive M&A space approaches $600 billion in Q1 202...
Procaps Group is a family-owned Latin American pharmaceutical company established over 40 years ago that has grown into a leading integrated pharma company with a presence in 13 countries and product reach in 50 markets modernizing oral drug delivery technology and manufacturing capab...
News, Short Squeeze, Breakout and More Instantly...
Union Acquisition Corp. II Company Name:
LATN Stock Symbol:
NASDAQ Market:
Third Quarter 2021 Net Revenues Increased 35% to $106.8 Million Year-Over-Year with Adjusted EBITDA Up 27% Year-Over-Year to $24.5 Million First Nine Months Net Revenues Increased 33% to $283.2 Million, with LTM Net Revenues at $401.4 Million and LTM Adjusted EBITDA up to $100...
Combined Company to Begin Trading on the Nasdaq Global Market® Under “PROC” and “PROCW” On September 30, 2021 Approximately $160 Million of Gross Proceeds Strategically Positions Procaps, a Leading Global Pharmaceutical Technology and Healthcar...
Union Acquisition Corp. II (“LATN”) Shareholders Approve the Proposed Business Combination with Procaps Group and the Parties Agree to Close by September 30, 2021 Following the Closing of the Business Combination the Combined Company is expected to Trade on the N...